University of California San Francisco
Give to UCSF
This year’s UCSF Founders Day Awards were given to 12 faculty, staff and students to recognize their contributions in the areas of public service, exceptional service to UC San Francisco and excellence in nursing.
School of Medicine Dean Talmadge E. King, Jr. announced the appointment of S. Andrew Josephson as the new chair of UCSF’s Department of Neurology, effective July 1.
In 2002, Deborah Yano-Fong became UCSF’s first chief privacy officer, overseeing all privacy-related policies and procedures for the medical center and the four UCSF graduate health sciences schools. Her team tackles the new challenges that have risen alongside new technologies that promise better care and better communication.
Since her days as a physician trainee, Diane Havlir, now Chief of the HIV, Infectious Diseases and Global Medicine Division at UCSF, has continued the crusade to end AIDS. She spoke about global HIV elimination at Fortune’s Brainstorm Health Conference in San Diego on May 2.
How T cells feel out intruders rapidly and reliably enough to nip infections and other threats in the bud has remained a mystery to researchers.
A test commonly used in breast cancer has been found to also identify which patients with aggressive prostate cancer will benefit from hormonal therapy.
The UCSF Medical Center has ranked No. 52 on the 2017 Forbes list of America’s Best Employers.
After a nationwide search, UCSF Fresno Medical Education Program recently announced the appointment of Ivan Albert Gomez as Chief of Family and Community Medicine and Vice-Chair of Family and Community Medicine at UCSF.
A campus entrance is one of 12 areas around UCSF selected for improvements through the First Impression Areas Contest.
The UCSF class of 2017 answers questions about challenges, lessons learned and advice they would give their first-year selves.
Of the nearly 6,000 physician mothers in the survey, nearly 78 percent reported discrimination of any type.
Researchers at UCSF and their colleagues have found that Hepatitis C virus (HCV) infection among people who inject drugs remains high and stable in some North American cities but incidence has dropped and remained low in some Australian and European cities.
